Fake news is spreading into medicine

Sarah Sipek | | Health Exec | Precision Medicine

Fake news has become a dominant talking point in the media in recent months, but it's not only running rampant on TVs and websites. Medical literature is also falling victim to the trend.

In recent years, many journals from mainstream publishers have appeared that are based entirely on pseudoscience. The Journal of Acupuncture and Meridian Studies, Acupuncture in Medicine and Chinese Medicine are three examples.

Unfortunately, according to a recent piece from Forbes, the existence of such journals can confuse medical students.

Click below to read the full story:

Fake Medical Journals Are Spreading, And They Are Filled With Bad Science

Sarah Sipek

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
Heartflow, a leader in AI-powered imaging evaluations, files for IPO

Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.

Cardiovascular Business
ASNC lobbies Congress to curb prior authorization, oppose AUC mandates and embrace payment reform

Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies. 

Cardiovascular Business
CMS proposal includes cardiologist pay bump—cuts to high-value services still a concern

The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services.